Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04000061 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Heart Failure-USB: Prediction and Progression

Study acronym: HF-USB
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Dec 31, 2026 → Apr 4, 2027
See other at-risk trials from University Hospital, Basel, Switzerland

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 31, 2026 to Apr 4, 2027
    • Eligibility criteria expanded, about 3 words
  2. Primary and study completion dates: Jul 2027 to Dec 31, 2026v6
  3. 2 versions Re-verified since Apr 11, 2022, no change to tracked fieldsv4-v5
  4. Enrollment target: 3000 to 6000
    • Primary and study completion dates: Jul 2022 to Jul 2027
    • Primary endpoints: 2 to 4
    • Eligibility criteria shortened, about 14 words
    v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
Trial Details
NCT Number NCT04000061
Lead Sponsor University Hospital, Basel, Switzerland
Conditions
(from sponsor)		 Acute Heart Failure, Acute Coronary Syndrome
Related terms Acute Coronary Syndrome
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov